Changes in serum uric acid, glutathione, and amyloid-β1-42 levels in Parkinson’s disease patients and their association with disease progression and cognitive decline
Serum UA, GSH, and Aβ1-42 are independent predictors of disease progression and cognitive decline in PD patients. Their combined use offers enhanced diagnostic accuracy for disease staging and cognitive impairment in PD.
Authors
- Bing Fu (ORCID: https://orcid.org/0000-0002-5861-5708)
- Jianhua Liu (ORCID: https://orcid.org/0009-0006-4821-3189)
- Qianqian He
- Jiechun Chen
- Zhaoting Zhang (ORCID: https://orcid.org/0000-0001-9760-1125)
Institutions
- The First People’s Hospital of Lianyungang (CN)
- Xian Yang Central Hospital (CN)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1080/03007995.2024.2422002
- Citations
- 2
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.74